{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-012173","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2026-03-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.011719+00:00","generated_at":"2026-05-15T09:22:53.155903+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Intelligent Bio grants restricted shares to CEO/CFO/directors; updates ATM facility","bullets":["CEO Harry Simeonidis and CFO Spiro Sakiris each receive 9,150 time-vesting and 21,350 performance-vesting restricted shares.","Directors awarded 20,000 time-vesting shares; non-executive employees get 10,500 time-vesting and 24,500 performance-vesting shares.","Total outstanding shares as of March 23, 2026: 2,001,173, reflecting grants and warrant exercises.","Up to $3,966,316 in shares available for sale under existing ATM agreement with Ladenburg Thalmann; new prospectus supplement filed.","Performance-vesting shares tied to clinical trial, FDA submission, and commercial milestones; vest over up to 10 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-012173","json":"https://secwatch.observer/filing/0001493152-26-012173.json","markdown":"https://secwatch.observer/filing/0001493152-26-012173.md","text":"https://secwatch.observer/filing/0001493152-26-012173.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/0001493152-26-012173-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:22:53.155903+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}